Vivek Garipalli - 17 Jun 2024 Form 4 Insider Report for CLOVER HEALTH INVESTMENTS, CORP. /DE (CLOV)

Role: Director, 10%+ Owner
Signature: /s/Peter J. Rivas as attorney-in-fact for Vivek Garipalli
Issuer symbol: CLOV
Transactions as of: 17 Jun 2024
Net transactions value: +$1,000,426
Form type: 4
Filing time: 20 Jun 2024, 16:03:32 UTC
Previous filing: 09 Jan 2024
Next filing: 13 Aug 2024
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	CLOV	Class A Common Stock	Purchase	$1,000,426	+877,567		$1.14	877,567	17 Jun 2024	Direct	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	The price reported in Column 4 is a weighted average price. These shares were bought in multiple transactions at prices ranging from $1.08 to $1.17, inclusive. The Reporting Person undertakes to provide to Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares bought at each separate price within the range set forth in this Footnote 1 to this Form 4.

Content

The price reported in Column 4 is a weighted average price. These shares were bought in multiple transactions at prices ranging from $1.08 to $1.17, inclusive. The Reporting Person undertakes to provide to Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares bought at each separate price within the range set forth in this Footnote 1 to this Form 4.